CRISPR Technology Market Size Worth USD 3.94 Billion By 2027 - PowerPoint PPT Presentation

About This Presentation

CRISPR Technology Market Size Worth USD 3.94 Billion By 2027


The growth of the market is attributed to growing availability of private and government funding coupled with increasing adoption of CRISPR technology – PowerPoint PPT presentation

Number of Views:30
Slides: 13
Provided by: ishadeshpande
Tags: forecast | growth | share | size | trend


Transcript and Presenter's Notes

Title: CRISPR Technology Market Size Worth USD 3.94 Billion By 2027

CRISPR Technology Market Size Worth USD 3.94
Billion By 2027
The growth of the market is attributed to growing
availability of private and government funding
coupled with increasing adoption of CRISPR
Our Model
Market Analysis
Financial Analysis
Distribution Channel Analysis
Brand Analysis
Custom Market Intelligence
Competitor Analysis
Product Analysis
Custom Research
Demand Analysis
Risk Analysis
Business Plan Parameters
End Use Analysis
Demand Availability Analytics
Market Entry Strategy
Restructuring Revival
New Product Strategy
Product Planning / Strategy
SWOT Analysis
Marketing / Distribution Channel Feasibility
Customer Identification Survey
Competitive Landscape / MA Feasibility
Industries We Cater to
Market Summary
The global CRISPR Technology Market is projected
to reach USD 3.94 billion by 2027, according to a
recent report by Emergen Research. Certain
factors that are driving the market growth
include increasing government and personal
funding, rising demand and adoption of CRISPR,
and technological advancements. The rise in
funding, initiatives by the government to develop
vaccines, medical technologies, drugs, devices
are propellant towards the expansion of the
genome editing market globally. As compared to
previous systems, CRISPR has a lot of potentials
and applications. Among these, one necessary
application is that the use of CRISPR in
understanding numerous genetic and epigenetic
diseases as well as cancer. Study of cancer by
the CRISPR system is usually done by 2 approaches
i.e. turning on the growth suppressor genes and
turning off the oncogenes. As per the precise
capability of CRISPR, this method may also be
used to make specific mutations in numerous cell
lines so as to model the cancers. This sort of
modeling may end up during a higher understanding
of a range of diseases like cancer and therefore
the ability to develop more effective medicine.
Market Summary
  • Some Key Highlights From the Report
  • Beam Therapeutics primarily owned by Feng Zhang
    started developing CRISPR officially declared in
    May 2018 because of which they were able to
    generate USD 87 million in series A funding. The
    main motive of the initiative was to utilize
    CRISPR technology in order to develop precision
    genetic medicines. This would further help to
    edit a single nucleotide base in the genome at
    one time.
  • In US, the first trial of CRISPR in humans began
    in April 2019. Two patients are currently being
    treated as a part of a study being conducted by
    University of Pennsylvania. In line with NPR
    (National Public Radio, America), each have
    different types of cancer that are tough to treat
    and each have relapsed normal treatments. As a
    part of the trial, researchers are taking immune
    cells from the patients' bodies and editing them
    with CRISPR after which theyre putting them
    back. Such novel research are expected to drive
    the market growth throughout the region.
  • Request Free Sample Copy_at_ https//www.emergenresea
Market Summary
For the purpose of this report, Emergen Research
has segmented into the global CRISPR Technology
Market on the basis of product type, application,
end user type and region Product Type Outlook
(Revenue, USD Billion 2017-2027) Enzymes Kits
and Reagents Guide RNA Others Applications
Outlook (Revenue, USD Billion 2017-2027) Biomedic
al Agricultural Industrial Others Read More_at_
Parameter Details
Market Size Estimation Period 2020-2028
Base Year Considered 2020
Historical Data 2017-2019
Forecast Period 2021-2028
Quantitative Units Revenue in USD million CAGR from 2020 to 2028
Segments Covered Types, Application, End-Users, Regions more.
Countries Included The U.S., Germany, U.K., Italy, China, India, Japan, Brazil
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Regions Scope North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Customization Scope 10 hours of free customization expert consultation
Pricing and Purchase Options Explore Different Purchase Options Request for Discount to Avail New Year Discount
Regional Share Dynamics
Latest published reports from the Healthcare
Sector by Emergen Research Diabetic
Ketoacidosis Market_at_ https//www.emergenresearch.c
om/industry-report/diabetic-ketoacidosis-market A
ctive Psoriatic Arthritis Market_at_
tive-psoriatic-arthritis-market Recurrent Atrial
Fibrillation Market_at_ https//www.emergenresearch.c
arket In-Vitro Diagnostics Market_at_
-vitro-diagnostics-market Enzymes Market_at_
About Us
At Emergen Research, we believe in advancing with
technology. We are a growing market research and
strategy consulting company with an exhaustive
knowledge base of cutting-edge and potentially
market-disrupting technologies that are predicted
to become more prevalent in the coming
decade. Our expertise umbrellas the
technological environment of all major
industries, and our services help you map your
actions to ensure optimal yield. Our analysts
utilize their market proficiency to offer
actionable insights that help our clients
implement profitable strategies and optimize
their return on investment. Our services are
wide-ranging, right from technological
environment analysis to technological profiling
that highlights the existing opportunities in the
market you can capitalize on to stay ahead of
your competitors.
Lets Talk Contact Information
Reach out to us and our Research Executives will
ensure you get the report that meets all your
requirements and address all your concerns.
14671 110 Avenue, Surrey, British Columbia, V3R2A9
1 (604) 757-9756
Write a Comment
User Comments (0)